WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy
The embattled diet brand said it is adding a compounded weight-loss drug in accordance with FDA rules and manufacturing standards. WeightWatchers announced on Tuesday that it will offer a compounded version of Novo Nordisk‘s popular weight-loss drug Wegovy as part of its weight-management programs,
WeightWatchers to offer compounded weight-loss drugs
WeightWatchers will begin selling compounded alternatives to certain weight-loss drugs that are experiencing shortages. Why it matters: Federal law allows companies to sell compounded versions of drugs that are on the FDA's shortages list — which has led to a surge of copycats to the newly popular class of GLP-1 injections.
WeightWatchers to offer compounded version of Novo Nordisk's weight-loss drug
WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of its weight-management programs, sending its shares nearly 47% higher to an over two-month closing high.
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
Men, Baby Boomers, and postgraduate degree-holders were among those most likely to say they wouldn’t choose medication over dieting.
WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications
WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight management interventions that are underpinned by the comprehensive,
Offering Wegovy and other weight loss drugs on Medicare could cost $35 billion
Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions of dollars, according to a new report by the Congressional Budget Office (CBO).
WW International: The Party Won't Last Long
WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...
Hold Rating on WW International Amid New Semaglutide Offering and Optimistic Revenue Projections
In a report released today, Alex Fuhrman from Craig-Hallum maintained a Hold rating on WW International (WW – Research Report), with a ...
The Crackdown on Compounded GLP-1 Meds Has Begun
Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...
WW International surges as Morgan Stanley says GLP-1 entry 'not too late'
WW International (WW) shares surged more than 20% in early trading on Wednesday after Morgan Stanley said the company's ...
Analyzing Risks and Margins: A Sell Rating for WW International’s New Semaglutide Venture
Stephanie Davis, an analyst from Barclays, maintained the Sell rating on WW International (WW – Research Report). The associated price ...
WeightWatchers offering compounded version of Ozempic, despite concerns expressed by FDA
High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...
What's Going With WeightWatchers Stock On Wednesday?
WeightWatchers stock rises after the company announces compounded semaglutide offerings, addressing GLP-1 shortages while ...
Compounded Semaglutide: Is It Safe and Effective?
Compounded semaglutide is semaglutide with an altered formula to create an unbranded alternative to Wegovy and Ozempic.
Investing1d
Why Are WeightWatchers (WW) Shares Soaring Today
Stock Story - What Happened? Shares of personal wellness company WeightWatchers (NASDAQ:WW) jumped 54.1% in the morning session on continued positive momentum after the company ex ...